loadpatents
name:-0.019307851791382
name:-0.010078907012939
name:-0.00037813186645508
Plata-Salaman; Carlos Patent Filings

Plata-Salaman; Carlos

Patent Applications and Registrations

Patent applications and USPTO patent grants for Plata-Salaman; Carlos.The latest application filed is for "use of sigma ligands in bone cancer pain".

Company Profile
0.10.14
  • Plata-Salaman; Carlos - Barcelona ES
  • Plata-Salaman; Carlos - Ambler PA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Sigma Ligands In Bone Cancer Pain
App 20130324535 - Zamanillo-Castanedo; Daniel ;   et al.
2013-12-05
1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
Grant 8,501,791 - Eisinger , et al. August 6, 2
2013-08-06
0novel, 1,2,4-thiadiazolium Derivatives As Melanocortin Receptor Modulators
App 20100280079 - Eisinger; Magdalena ;   et al.
2010-11-04
1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
Grant 7,786,311 - Eisinger , et al. August 31, 2
2010-08-31
Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
App 20090203751 - Eisinger; Magdalena Eisinger ;   et al.
2009-08-13
Neuroprotective Peptides
App 20090170759 - Smith-Swintosky; Virginia ;   et al.
2009-07-02
1,2,4-thiadiazole derivatives as melanocortin receptor modulators
Grant 7,375,123 - Eisinger , et al. May 20, 2
2008-05-20
1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
Grant 7,319,107 - Eisinger , et al. January 15, 2
2008-01-15
Neuroprotective peptides
Grant 7,259,146 - Smith-Swintosky , et al. August 21, 2
2007-08-21
Anticonvulsant derivatives useful for preventing the development of type II diabetes mellitus and syndrome X
Grant 7,109,174 - Plata-Salaman , et al. September 19, 2
2006-09-19
Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
App 20060128772 - Eisinger; Magdalena ;   et al.
2006-06-15
1,2,4-thiadiazole derivatives as melanocortin receptor modulators
Grant 7,049,331 - Eisinger , et al. May 23, 2
2006-05-23
Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
App 20060030604 - Elsinger; Magdalena ;   et al.
2006-02-09
Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
Grant 6,908,902 - Plata-Salaman , et al. June 21, 2
2005-06-21
Anticonvulsant derivatives useful for preventing the development of Type II diabetes mellitus and Syndrome X
Grant 6,852,701 - Plata-Salaman , et al. February 8, 2
2005-02-08
Anticonvulsant derivatives useful for preventing the development of type II diabetes mellitus and syndrome X
App 20040209824 - Plata-Salaman, Carlos ;   et al.
2004-10-21
Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
App 20030176425 - Eisinger, Magdalena ;   et al.
2003-09-18
Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
App 20030162819 - Eisinger, Magdalena ;   et al.
2003-08-28
Neuroprotective peptides
App 20030130197 - Smith-Swintosky, Virginia ;   et al.
2003-07-10
Alpha7 nicotinic receptor peptides as ligands for beta amyloid peptides
App 20030092613 - Lee, Daniel H. S. ;   et al.
2003-05-15
Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
App 20020169109 - Plata-Salaman, Carlos ;   et al.
2002-11-14
Anticonvulsant derivatives useful for preventing the development of Type II diabetes mellitus and Syndrome X
App 20020037861 - Plata-Salaman, Carlos ;   et al.
2002-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed